Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Job Summary –
We are seeking an intelligent, creative, and collegial post-doctoral research fellow to join a laboratory addressing basic and translational approaches in human breast carcinomas with an emphasis on triple negative breast cancers. We perform basic science and human translational work towards identifying and targeting genomic and immunologic dependencies to improve patient outcomes. Research areas include development of models to define triple negative breast cancer biology and therapeutic targets and analysis of patient derived xenografts and tissues for therapeutic targeting. We are a highly collaborative group and interact closely with cancer biologists, clinicians, and computational biologists to comprehensively understand breast cancer biology.
We are seeking an enthusiastic bench-level scientist to join our project team. The major focus of this position will be to further develop a microfluidic assay to test drug response in triple negative breast cancers and to study the immune microenvironment.
Specific responsibilities include
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.